Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target [2]

P. E. Thorpe, F. J. Burrows

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)241-242
Number of pages2
JournalBreast Cancer Research and Treatment
Volume39
Issue number2
StatePublished - 1996

Fingerprint

Neoplasms
Endoglin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target [2]. / Thorpe, P. E.; Burrows, F. J.

In: Breast Cancer Research and Treatment, Vol. 39, No. 2, 1996, p. 241-242.

Research output: Contribution to journalArticle

@article{a7698f225d9649ddbaaf5dc88777e8b1,
title = "Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target [2]",
author = "Thorpe, {P. E.} and Burrows, {F. J.}",
year = "1996",
language = "English (US)",
volume = "39",
pages = "241--242",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target [2]

AU - Thorpe, P. E.

AU - Burrows, F. J.

PY - 1996

Y1 - 1996

UR - http://www.scopus.com/inward/record.url?scp=0029810069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029810069&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 241

EP - 242

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -